臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"jia horng kao"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 681-705 of 1180 (48 Page(s) Totally)
<< < 23 24 25 26 27 28 29 30 31 32 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2021-09-04T05:16:27Z	Reply to letter to the editor: Successful eradication of HCV by short-course DAAs in HCV positive donor to HCV-Negative recipient during Haplo-HSCT	Huang C.-F.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:16:27Z	The association of vitamin D with hepatitis B virus replication: Bystander rather than offender	Wang C.-C.; Tzeng I.-S.; Su W.-C.; Li C.-H.; Lin H.H.; Yang C.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:16:27Z	High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy	Chang W.-Y.; Chiu Y.-C.; Chiu F.-W.; Hsu Y.-C.; Tseng T.-C.; Cheng P.-N.; Yang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:16:26Z	Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis	Hsu W.-F.; Chen C.-Y.; Tseng K.-C.; Lai H.-C.; Kuo H.-T.; Hung C.-H.; Tung S.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Lin C.-Y.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; JIA-HORNG KAO; Liu C.-J.; Liu C.-H.; Yan S.-L.; Bair M.-J.; Su W.-W.; Chu C.-H.; Chen C.-J.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Tsai P.-C.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Yu M.-L.; Peng C.-Y.
臺大學術典藏	2021-09-04T05:16:26Z	Highlights	JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:16:26Z	East Asia expert opinion on treatment initiation for chronic hepatitis B	JIA-HORNG KAO; Hu T.-H.; Jia J.; Kurosaki M.; Lim Y.-S.; Lin H.-C.; Sinn D.H.; Tanaka Y.; Wai-Sun Wong V.; Yuen M.-F.
臺大學術典藏	2021-09-04T05:16:25Z	The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease	Eslam M.; Sarin S.K.; Wong V.W.-S.; Fan J.-G.; Kawaguchi T.; Ahn S.H.; Zheng M.-H.; Shiha G.; Yilmaz Y.; Gani R.; Alam S.; Dan Y.Y.; JIA-HORNG KAO; Hamid S.; Cua I.H.; Chan W.-K.; Payawal D.; Tan S.-S.; Tanwandee T.; Adams L.A.; Kumar M.; Omata M.; George J.
臺大學術典藏	2021-09-04T05:16:25Z	Sofosbuvir/velpatasvir/voxilaprevir plus ribavirin for chronic hepatitis C patients with direct acting antiviral failures: Implications for viral elimination in Taiwan	Liu C.-H.; Su T.-H.; Liu C.-J.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:16:25Z	Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis	Liu C.-H.; Peng C.-Y.; Fang Y.-J.; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; Su T.-H.; Liu C.-J.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:16:24Z	Hepatitis C virus cure rates are reduced in patients with active but not inactive hepatocellular carcinoma: A practice implication	Ogawa E.; Toyoda H.; Iio E.; Jun D.W.; Huang C.-F.; Enomoto M.; Hsu Y.-C.; Haga H.; Iwane S.; Wong G.; Lee D.H.; Tada T.; Liu C.-H.; Chuang W.-L.; Hayashi J.; Cheung R.; Yasuda S.; Tseng C.-H.; Takahashi H.; Tran S.; Yeo Y.H.; Henry L.; Barnett S.D.; Nomura H.; Nakamuta M.; Dai C.-Y.; Huang J.-F.; Yang H.-I.; Lee M.-H.; Jun M.J.; JIA-HORNG KAO; Eguchi Y.; Ueno Y.; Tamori A.; Furusyo N.; Yu M.-L.; Tanaka Y.; Nguyen M.H.; Ahn S.B.; Azuma K.; Dohmen K.; Jeong J.Y.; Jung J.H.; Kajiwara E.; Kato M.; Kawano A.; Koyanagi T.; Ooho A.; Park S.H.; Satoh T.; Shimoda S.; Song D.S.; Takahashi K.; Yeh M.-L.; Yoon E.L.; Real-World Evidence from the Asia Liver Consortium Investigators
臺大學術典藏	2021-09-04T05:16:24Z	Highlights	JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:16:24Z	Letter: elevated aspartate aminotransferase and aspartate aminotransferase to alanine aminotransferase ratio predicts poor survival in hepatocellular carcinoma after resection—Authors' reply	Wai-Sun Wong V.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:16:23Z	Improved second harmonic generation and two-photon excitation fluorescence microscopy-based quantitative assessments of liver fibrosis through auto-correction and optimal sampling	Hsiao C.-Y.; Teng X.; Su T.-H.; Lee P.-H.; JIA-HORNG KAO; Huang K.-W.
臺大學術典藏	2021-09-04T05:16:23Z	Reply to: “Sofosbuvir and the risk of kidney dysfunction”	Liu C.-H.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:16:23Z	Letter: elevated HBV DNA predicts poor survival in hepatocellular carcinoma after hepatic resection—authors' reply	Tseng T.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:16:22Z	APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients	JIA-HORNG KAO; Jeng W.-J.; Ning Q.; Su T.-H.; Tseng T.-C.; Ueno Y.; Yuen M.-F.
臺大學術典藏	2021-09-04T05:16:22Z	Iodized oil computed tomography versus ultrasound-guided radiofrequency ablation for early hepatocellular carcinoma	Wu C.-H.; Liang P.-C.; Su T.-H.; Lin M.-C.; Chang Y.-H.; Shih T.T.-F.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:16:21Z	Response to letter to the editor “Factors predicting outcomes of hepatitis B-related cirrhosis patients with long-term antiviral therapy”	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:16:21Z	Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis	Su T.-H.; Peng C.-Y.; Chang S.-H.; Tseng T.-C.; Liu C.-J.; Chen C.-L.; Liu C.-H.; Yang H.-C.; Chen P.-J.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:16:21Z	Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)	Yeh M.-L.; Hung C.-H.; Tseng K.-C.; Lai H.-C.; Chen C.-Y.; Kuo H.-T.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; JIA-HORNG KAO; Liu C.-H.; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Huang C.-F.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Tsai P.-C.; Peng C.-Y.; Liu C.-J.; Yu M.-L.
臺大學術典藏	2021-09-04T05:16:21Z	Systemic therapy for hepatocellular carcinoma: New agents and therapeutic hierarchy	Su T.-H.; Hsu S.-J.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:16:20Z	Characteristics of patients with hepatitis C virus infection and antiviral treatment initiation in Taiwan: The MOSAIC study	Yu M.-L.; Tsai W.-L.; Chu C.-J.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:16:20Z	Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients	Liu M.; Tseng T.-C.; Jun D.W.; Yeh M.-L.; Trinh H.; Wong G.L.H.; Chen C.-H.; Peng C.-Y.; Kim S.E.; Oh H.; Kwak M.-S.; Cheung M.; Toyoda H.; Hsu Y.-C.; Jeong J.Y.; Yoon E.L.; Ungtrakul T.; Zhang J.; Xie Q.; Ahn S.B.; Enomoto M.; Shim J.-J.; Cunningham C.; Jeong S.W.; Cho Y.K.; Ogawa E.; Huang R.; Lee D.-H.; Takahashi H.; Tsai P.-C.; Huang C.-F.; Dai C.-Y.; Tseng C.-H.; Yasuda S.; Kozuka R.; Li J.; Wong C.; Wong C.C.; Zhao C.; Hoang J.; Eguchi Y.; Wu C.; Tanaka Y.; Gane E.; Tanwandee T.; Cheung R.; Yuen M.-F.; Lee H.-S.; Yu M.-L.; JIA-HORNG KAO; Yang H.-I.; Nguyen M.H.
臺大學術典藏	2021-09-04T05:16:20Z	One-year Fibrosis-4 index helps identify minimal HCC risk in non-cirrhotic chronic hepatitis B patients with antiviral treatment	Tseng T.-C.; Choi J.; Nguyen M.H.; Peng C.-Y.; Siakavellas S.; Papatheodoridis G.; Wang C.-C.; Lim Y.-S.; Lai H.-C.; Trinh H.N.; Wong C.; Wong C.; Zhang J.; Li J.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T05:16:19Z	Response to letter to the editor “The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma”	Cheng Y.-M.; Tzeng I.-S.; JIA-HORNG KAO; Wang C.-C.

Showing items 681-705 of 1180 (48 Page(s) Totally)
<< < 23 24 25 26 27 28 29 30 31 32 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 0
	???header.visitor??? : 51496312 ???header.onlineuser??? : 726 ???header.sponsordeclaration???